NewswireToday - /newswire/ -
Monrovia, CA, United States, 2013/12/16 - Investment Opportunities Panel at the Diabetes Partnering and Deal-Making Conference on April 23-25, 2014 in Cambridge, MA by GTC - GTCbio.com.
GTC’s 4th Diabetes Partnering and Deal-Making Conference will feature a panel discussion on Investment Opportunities in the Diabetes Space.
The panelists include:
• Richard Caroddo, Senior Business Development Executive at Medpace;
• Jeff Karan, Founder and Senior Partner at Woodside Capital;
• Bart Henderson, President & Founder of RhythmRX;
• Mostafa Analoui, Head of Healthcare and Life Sciences at Livingston Securities.
The panel will discuss the current climate for private and public investment in diabetes, recent transactions and exits in therapeutics and devices, outlook for future investments and deals and much more.
The Diabetes Partnering & Deal-Making Conference is part of GTC’s annual Diabetes Summit which has evolved to be the go-to conference to learn about the latest research and partnership opportunities, and to network with academia, venture capital, government, biotech, pharma and healthcare organizations. We invite you to join delegates from across the world at the 2014 Diabetes Summit. The program will provide you with opportunities to further your understanding of the diabetes field through presentations and panel discussions.
The Diabetes Summit 2014 consists of two co-located conferences:
I. 4th Diabetes Partnering and Deal-Making Conference highlights pre-clinical and early clinical research, emerging therapeutic targets, and update guests on clinical developments.
II. 7th Diabetes Drug Discovery and Development Conference discusses opportunities for partnerships, funding, licensing, and merger and acquisitions.